Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
01/18/2011 | US7872140 contacting (S)-omeprazole freebase or its sodium/potassium salt with inorganic or organic acid salt of the barium (barium chloride, barium sulfate, barium oxalate, barium acetate) in a suitable solvent ( methanol)in presence of a base ( NaOH) to form (S)-omeprazole barium; helicobacter infections |
01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
01/18/2011 | US7872098 derivatives of peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY pharmaceutical compositions; capable of stimulating in vitro the proliferation and the secretion of IL-2 by the CD4+ T cells purified from the ganglia |
01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
01/18/2011 | US7872025 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
01/18/2011 | US7871992 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
01/18/2011 | US7871631 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
01/18/2011 | CA2500225C Pyrazole compounds |
01/18/2011 | CA2477773C A stable diclofenac-tromethamine composition for the topical treatment of oropharyngeal cavity disorders |
01/18/2011 | CA2458797C Preparation and diabetic use of gibeberellins |
01/18/2011 | CA2436825C Process for the crystallization of (r)- or (s)-lansoprazole |
01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
01/18/2011 | CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
01/18/2011 | CA2320807C Method and composition for treatment of inflammatory conditions |
01/18/2011 | CA2269895C Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract |
01/13/2011 | WO2011005609A2 Imaging gastrointestinal volumes and motility |
01/13/2011 | WO2011005142A1 Method for treating liver diseases of various origins |
01/13/2011 | WO2011004882A1 Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
01/13/2011 | WO2011004837A1 Antibody having anti-cancer activity |
01/13/2011 | WO2011004799A1 Tablet having hollow structure |
01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
01/13/2011 | WO2011003995A1 Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution |
01/13/2011 | WO2010133906A3 Use of specific chelating polymers in medicaments for the treatment of inflammatory bowel disease |
01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
01/13/2011 | US20110009625 Novel compounds |
01/13/2011 | US20110009491 Process for producing 1,4-dihydroxy-2-naphthoic acid |
01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
01/13/2011 | US20110009443 Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors |
01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
01/13/2011 | US20110009431 Compositions and methods for treating fibroproliferative disorders |
01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
01/13/2011 | US20110009416 PH INDEPENDENT FORMULATIONS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE |
01/13/2011 | US20110009407 Pyridinone antagonists of alpha-4 integrins |
01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
01/13/2011 | US20110009379 Indolinone compound |
01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
01/13/2011 | US20110009362 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof |
01/13/2011 | US20110009359 Use of non-digestible carbohydrates for improving intestinal microbiota |
01/13/2011 | US20110009348 Carbohydrate gel |
01/13/2011 | US20110009344 Control of radiation injury |
01/13/2011 | US20110009320 Glucagon-like peptide-2 analogs |
01/13/2011 | US20110009316 Proteolysis resistant active vegf |
01/13/2011 | US20110008476 Methods of Treating or Preventing Inflammatory Diseases of the Intestinal Tract |
01/13/2011 | US20110008449 Human Specific Escherichia Coli Strains |
01/13/2011 | US20110008432 Method for Treating a Patient in Need of Aspirin Therapy |
01/13/2011 | US20110008423 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
01/13/2011 | US20110008362 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
01/13/2011 | US20110008352 Toll-Like Receptor 3 Antagonists |
01/13/2011 | US20110008340 Anti-properdin antibodies |
01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
01/13/2011 | US20110008291 Use of antifungal compositions to treat upper gastrointestinal conditions |
01/13/2011 | US20110008285 Novel cyclosporin analogues |
01/13/2011 | US20110008284 Novel clyclosporin analogues |
01/13/2011 | US20110008268 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
01/13/2011 | US20110008259 Modulators of cystic fibrosis transmembrane conductance regulator |
01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
01/13/2011 | CA2767442A1 Antibody having anti-cancer activity |
01/13/2011 | CA2767143A1 Tablet having hollow structure |
01/13/2011 | CA2765529A1 Acid pump antagonist for treatment of diseases involved in abnormal gastrointestinal motility |
01/13/2011 | CA2760008A1 Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution |
01/12/2011 | EP2273419A1 Methods of treating and preventing colitis involving IL-13 and NK-T cells |
01/12/2011 | EP2272844A1 Five-membered ring compound |
01/12/2011 | EP2272841A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
01/12/2011 | EP2272835A1 Novel five-membered ring compound |
01/12/2011 | EP2272833A1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
01/12/2011 | EP2272832A1 Phenylpropionic acid derivative and use thereof |
01/12/2011 | EP2272825A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation |
01/12/2011 | EP2272523A1 Compounds, compositions, formulations and process for preparation thereof and method of treatment and management of acidity and related disorders |
01/12/2011 | EP2272522A2 Therapeutic compositions for use in prophylaxis or treatment of diarrheas |
01/12/2011 | EP2272520A1 Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients |
01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
01/12/2011 | EP2271405A2 Nip thiazole derivatives as inhibitors of 11-beta-hydorxysteroid dehydrogenase-1 |
01/12/2011 | EP2271351A2 Compositions and methods for treating viral infections |
01/12/2011 | EP2271334A2 Methods of treating fibrotic disorders |
01/12/2011 | EP2192896B1 Carbonylamino derivatives useful for the treatment of inflammatory bowel disease |
01/12/2011 | EP1490357B1 Toluene solvate of darifenacin |
01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
01/12/2011 | EP1401458B1 Composition consisting of phy906 and chemotherapeutic agents |
01/12/2011 | CN201701876U Membrane separating system for extracting bioactive compositions from bamboo leaves |